shutterstock_728117296_-nicolo-zangirolami

Nicolo Zangirolami / Shutterstock.com

30 September 2019BiotechnologyMaxim Sobolev

Secondary patents: Moscow mewl

The Russian IP ombudsman Anatoly Semenov has written to the Russian lower house, the State Duma, drawing its attention to the increasing number of patent conflicts among pharmaceutical manufacturers in Russia and urged the Duma to legislate to address the issue.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

UPC bans Meril Life Sciences from selling infringing heart valve

‘We took Ravgen head-on’: How we won zero-damages and others didn't

White & Case hires experienced litigator from A&O Shearman

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sanofi subsidiary fends off $450m trade secrets case

Pfizer infringed haemophilia therapy patent, says court

Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar